首页> 美国卫生研究院文献>Springer Open Choice >The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles
【2h】

The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles

机译:乙型肝炎病毒核心变异体在病毒样颗粒的外表面暴露出外来的C末端插入物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The major immunodominant region (MIR) and N-terminus of the hepatitis B virus (HBV) core (HBc) protein were used to expose foreign insertions on the outer surface of HBc virus-like particles (VLPs). The additions to the HBc positively charged arginine-rich C-terminal (CT) domain are usually not exposed on the VLP surface. Here, we constructed a set of recombinant HBcG vectors in which CT arginine stretches were substituted by glycine residues. In contrast to natural HBc VLPs and recombinant HBc VLP variants carrying native CT domain, the HBcG VLPs demonstrated a lowered capability to pack bacterial RNA during expression in Escherichia coli cells. The C-terminal addition of a model foreign epitope from the HBV preS1 sequence to the HBcG vectors resulted in the exposure of the inserted epitope on the VLP surface, whereas the same preS1 sequences added to the native CT of the natural HBc protein remained buried within the HBc VLPs. Based on the immunisation of mice, the preS1 epitope added to the HBcG vectors as a part of preS1(20–47) and preS1phil sequences demonstrated remarkable immunogenicity. The same epitope added to the original C-terminus of the HBc protein did not induce a notable level of anti-preS1 antibodies. HBcG vectors may contribute to the further development of versatile HBc VLP-based vaccine and gene therapy applications.
机译:乙型肝炎病毒(HBV)核心(HBc)蛋白的主要免疫优势区(MIR)和N末端用于暴露HBc病毒样颗粒(VLP)外表面上的异物插入。 HBc带正电的富含精氨酸的C末端(CT)域的添加物通常不暴露在VLP表面上。在这里,我们构建了一组重组HBcG载体,其中CT精氨酸段被甘氨酸残基取代。与天然HBc VLP和携带天然CT结构域的重组HBc VLP变体相比,HBcG VLP在大肠杆菌细胞中表达时表现出降低包装细菌RNA的能力。从HBV preS1序列到HBcG载体的C型末端外来抗原表位的C末端添加导致插入的表位暴露于VLP表面,而添加到天然HBc蛋白天然CT的相同preS1序列仍被掩埋在HBc VLP。基于对小鼠的免疫接种,作为preS1(20-47)和preS1phil序列的一部分添加到HBcG载体中的preS1表位显示出显着的免疫原性。添加到HBc蛋白原始C端的相同表位不会诱导显着水平的抗preS1抗体。 HBcG载体可能有助于基于HBc VLP的多功能疫苗和基因治疗应用的进一步发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号